...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: ASN late breaker and CKD sub-study top-line

3 abstracts for Resverlogix at ASN. Thanks Barsax for posting over on Stockhouse! Posters 317 and 1048 are on Friday Nov 8th. Poster 782 is on Saturday Nov 9th. None of them are the BETonMACE CKD sub-study. I don't see anything Resverlogix/Apabetalone/Resverlogix related in the list of late breakers. Click on the links below for the abstracts.

1048: Apabetalone Lowers Serum Alkaline Phosphatase in CVD Patients with and Without CKD and Improves Cardiovascular Risk

317: Association of Serum Alkaline Phosphatase with CKD and Cognitive Function in Patients with Diabetes and Acute Coronary Syndrome

782: Apabetalone Downregulates Alkaline Phosphatase and Improves Cardiovascular Risk

Share
New Message
Please login to post a reply